Transaction DateRecipientSharesTypePriceValue
2nd September 2020James R Tobin5,600Exercise of derivative$26.27$147,112.00
2nd September 2020James R Tobin5,600Open or private sale$56.85$318,360.00
1st September 2020John F Carey2,000Exercise of derivative$0.39$780.00
1st September 2020John F Carey2,000Open or private sale$17.59$35,180.00
25th August 2020James R Tobin17,400Exercise of derivative$26.27$457,098.00
25th August 2020James R Tobin17,400Open or private sale$54.40$946,560.00
17th August 2020Ventures Fund Iv General Partner Llc Flagship1,449,190Other acquisition or disposition$0.00
17th August 2020Ventures Fund Iv General Partner Llc Flagship2,053,049Other acquisition or disposition$0.00
17th August 2020Ventures Fund Iv General Partner Llc Flagship7,550,810Other acquisition or disposition$0.00
3rd August 2020John F Carey1,858Open or private sale$18.58$34,521.64
Trans Medics Group
Trans Medics Group logo

TransMedics Group, Inc. focuses on the preservation of human organs for transplant in a near-physiologic condition. The company was founded by Waleed H. Hassanein in October 2018.

Ticker: TMDX
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 1756262
Employees: 109
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals